| Product Code: ETC10600409 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Human Immunodeficiency Virus Type Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Human Immunodeficiency Virus Type Market - Industry Life Cycle |
3.4 Mexico Human Immunodeficiency Virus Type Market - Porter's Five Forces |
3.5 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Medication Class, 2021 & 2031F |
3.7 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.8 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
3.9 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume Share, By Treatment Goals, 2021 & 2031F |
4 Mexico Human Immunodeficiency Virus Type Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about HIV prevention and treatment in Mexico |
4.2.2 Government initiatives and investments in healthcare infrastructure and HIV programs |
4.2.3 Technological advancements in HIV testing and treatment |
4.3 Market Restraints |
4.3.1 Stigma and discrimination associated with HIV/AIDS leading to underreporting and lack of access to care |
4.3.2 Limited healthcare resources and funding for HIV programs |
4.3.3 Socioeconomic disparities affecting access to HIV treatment and care |
5 Mexico Human Immunodeficiency Virus Type Market Trends |
6 Mexico Human Immunodeficiency Virus Type Market, By Types |
6.1 Mexico Human Immunodeficiency Virus Type Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Antiretroviral Therapy, 2021 - 2031F |
6.1.4 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Pre-exposure Prophylaxis, 2021 - 2031F |
6.1.5 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-exposure Prophylaxis, 2021 - 2031F |
6.1.6 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Adjuvant Therapy, 2021 - 2031F |
6.2 Mexico Human Immunodeficiency Virus Type Market, By Medication Class |
6.2.1 Overview and Analysis |
6.2.2 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Nucleoside Reverse Transcriptase Inhibitors, 2021 - 2031F |
6.2.3 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Integrase Strand Transfer Inhibitors, 2021 - 2031F |
6.2.4 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Protease Inhibitors, 2021 - 2031F |
6.2.5 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 Mexico Human Immunodeficiency Virus Type Market, By Delivery Method |
6.3.1 Overview and Analysis |
6.3.2 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.5 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Injectable/Oral, 2021 - 2031F |
6.4 Mexico Human Immunodeficiency Virus Type Market, By Patient Group |
6.4.1 Overview and Analysis |
6.4.2 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-Positive Adults, 2021 - 2031F |
6.4.3 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By High-Risk Populations, 2021 - 2031F |
6.4.4 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Healthcare Workers, 2021 - 2031F |
6.4.5 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Pregnant Women, 2021 - 2031F |
6.5 Mexico Human Immunodeficiency Virus Type Market, By Treatment Goals |
6.5.1 Overview and Analysis |
6.5.2 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Viral Suppression, 2021 - 2031F |
6.5.3 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV Prevention, 2021 - 2031F |
6.5.4 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By Post-Exposure Prevention, 2021 - 2031F |
6.5.5 Mexico Human Immunodeficiency Virus Type Market Revenues & Volume, By HIV-1 Transmission Prevention, 2021 - 2031F |
7 Mexico Human Immunodeficiency Virus Type Market Import-Export Trade Statistics |
7.1 Mexico Human Immunodeficiency Virus Type Market Export to Major Countries |
7.2 Mexico Human Immunodeficiency Virus Type Market Imports from Major Countries |
8 Mexico Human Immunodeficiency Virus Type Market Key Performance Indicators |
8.1 Percentage of population receiving regular HIV testing |
8.2 Number of healthcare facilities offering HIV treatment and support services |
8.3 HIV viral suppression rate among diagnosed individuals |
9 Mexico Human Immunodeficiency Virus Type Market - Opportunity Assessment |
9.1 Mexico Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Mexico Human Immunodeficiency Virus Type Market Opportunity Assessment, By Medication Class, 2021 & 2031F |
9.3 Mexico Human Immunodeficiency Virus Type Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.4 Mexico Human Immunodeficiency Virus Type Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
9.5 Mexico Human Immunodeficiency Virus Type Market Opportunity Assessment, By Treatment Goals, 2021 & 2031F |
10 Mexico Human Immunodeficiency Virus Type Market - Competitive Landscape |
10.1 Mexico Human Immunodeficiency Virus Type Market Revenue Share, By Companies, 2024 |
10.2 Mexico Human Immunodeficiency Virus Type Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here